皮肤病学临床试验中的自适应设计:当前状况和未来前景
D Potvin1, P D'Angelo1, S Bennett1
1Innovaderm Research Inc, Montreal, Quebec, Canada.
概括
适应性试验设计为临床试验提供了灵活和高效的方法,减少非瘤性皮肤疾病的成本和开发时间. 这些创新方法可以限制患者接触不有效的治疗方法,提高研究完成率.
科学领域:
- 皮肤病学 皮肤病学
- 临床试验设计 临床试验设计
- 药物开发 药物开发
背景情况:
- 传统药物开发面临着监管障碍和效率低下.
- 适应性试验设计正在成为临床研究的灵活替代方案.
研究的目的:
- 探索适应性试验设计在非瘤性皮肤疾病中的应用.
- 审查常见的适应性设计,运营挑战和统计考虑.
- 提出成功实施的战略,并确定最佳的使用案例.
主要方法:
- 皮肤学研究当前适应性试验设计的审查.
- 分析运营和统计方面的挑战.
- 识别适应性设计的有利和不利情景.
主要成果:
- 适应性设计提供了潜在的好处,如降低成本和更快的开发时间表.
- 突出了常见的适应性设计及其在皮肤病学中的特定应用.
- 讨论了实施的运营和统计方面的考虑.
结论:
- 适应性试验设计在非瘤性皮肤疾病中为药物开发提供了有希望的,高效的方法.
- 成功实施需要仔细考虑运营和统计因素.
- 了解特定的用例对于最大限度地发挥自适应设计的好处至关重要.
更多相关视频
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.2K
06:30Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
Published on: May 17, 2021
4.1K
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Structure-Activity Relationships and Drug Design
710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
